Sildenafil Citrate Tablet, Film Coated
Product Images NDC 68788-4111

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 68788-4111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Description (Logo1)

Image Description (Logo1)
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
This text provides information on the change in systolic blood pressure (SBP) measured in mmHg over time postdose for two different treatment groups - one receiving Doxazosin and Placebo, and the other Doxazosin and Sildenafil 50 mg. The table displays the SBP values at different time points postdose for both treatment groups.*
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
This text appears to list different treatment groups using doxazosin and either sildenafil or a placebo. The time after dosing is also indicated on the chart.*
FDA Label Image

Figure-5 (Figure 5)

Figure-5 (Figure 5)
This text provides information on plasma concentrations measured in ng/ml over time (in hours) after the dose of a commercial tablet treatment.*
FDA Label Image

Figure-6-1 (Figure 6 1)

Figure-6-1 (Figure 6 1)
This data appears to be showing the percentage of patients at different score levels at the endpoint of a study. It includes percentages ranging from 80% to 1%. It seems to be a comparison of patients' baseline scores with their scores at the endpoint of the study.*
FDA Label Image

Figure-6-2 (Figure 6 2)

Figure-6-2 (Figure 6 2)
FDA Label Image

Figure-7 (Figure 7)

Figure-7 (Figure 7)
This data shows the percentage of patients reporting improvement for different dosages of sildenafil citrate compared to a placebo. The patients were divided into groups based on the dosage they received - 25mg, 50mg, 100mg, and placebo. The numbers of patients in each group are also provided (n=463 for placebo, n=214 for 25mg, n=391 for 50mg, and n=380 for 100mg).*
FDA Label Image

Sildenafil Tablets 100mg (Sildenafiltablet 100mg 30tablets Indrad)

Sildenafil Tablets 100mg (Sildenafiltablet 100mg 30tablets Indrad)
This text appears to be a description of Sildenafil Tablets 100mg, a generic version of Viagra. It highlights caution in accordance with federal law, advising against transferring the drug to anyone other than the prescribed patient. The tablets contain Sildenafil citrate USP equivalent to 100mg of sildenafil. It also mentions the manufacturer, Torrent Pharmaceuticals Limited. The tablets are described as oval, blue, and imprinted. The packaging information includes details like batch number, expiration date, and quantity. Additionally, precautions are given to store the tablets out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.